Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (321-330 of 434) with videos related to

Pageof 44
Sort By:
Blood|May 3, 2002
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML IntergroupStéphanie Nguyen, Thierry Leblanc, Pierre Fenaux, et al.
Bulletin Du Cancer|May 11, 2020
COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)André Baruchel, Yves Bertrand, Nicolas Boissel, et al.
Haematologica|October 7, 2008
Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcomePaola Ballerini, Judith Landman-Parker, Jean Michel Cayuela, et al.
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Haematologica|May 15, 2012
Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocolVirginie Gandemer, Sylvie Chevret, Arnaud Petit, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
BMC Cancer|January 16, 2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 studyVirginie Gandemer, Marie-Francoise Auclerc, Yves Perel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric OncologyC Coze, O Hartmann, J Michon, et al.
Haematologica|January 25, 2015
Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. programVincent Barlogis, Pascal Auquier, Yves Bertrand, et al.
Pageof 44

Showing results (321-330 of 434) with videos related to

Sort By:
Pageof 44
Blood|May 3, 2002
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML IntergroupStéphanie Nguyen, Thierry Leblanc, Pierre Fenaux, et al.
Bulletin Du Cancer|May 11, 2020
COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)André Baruchel, Yves Bertrand, Nicolas Boissel, et al.
Haematologica|October 7, 2008
Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcomePaola Ballerini, Judith Landman-Parker, Jean Michel Cayuela, et al.
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Haematologica|May 15, 2012
Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocolVirginie Gandemer, Sylvie Chevret, Arnaud Petit, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
BMC Cancer|January 16, 2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 studyVirginie Gandemer, Marie-Francoise Auclerc, Yves Perel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric OncologyC Coze, O Hartmann, J Michon, et al.
Haematologica|January 25, 2015
Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. programVincent Barlogis, Pascal Auquier, Yves Bertrand, et al.
Pageof 44